Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | GLA | P06280 | 2/20 | 0.51 |
| ▸ | HTR1A | P08908 | 14/20 | 0.50 |
| ▸ | HTR1B | P28222 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | DRD4 | P21917 | 2/20 | 0.46 |
| ▸ | DRD3 | P35462 | 2/20 | 0.46 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5756503 | 1.00 | ALDH1A1 (0.51) | ALDH1A1GLAHTR1AHTR1BMEN1 | |
| SCHEMBL7884121 | 1.00 | ALDH1A1 (0.51) | ALDH1A1GLAHTR1AHTR1BMEN1 | |
| SCHEMBL29989447 | 1.00 | ALDH1A1 (0.51) | ALDH1A1GLAHTR1AHTR1BMEN1 | |
| Ethyl Acetate SCHEMBL11383858 | 0.86 | ALDH1A1 (0.45) | ALDH1A1GLAHTR1AHTR1BMEN1 | |
| SCHEMBL7876324 | 0.85 | HTR1A (0.54) | HTR1AHTR1BMEN1MAPK1KMT2A | |
| SCHEMBL9449978 | 0.85 | ALDH1A1 (0.47) | ALDH1A1GLAHTR1AHTR1BMEN1 | |
| SCHEMBL19089581 | 0.85 | HTR1A (0.54) | ALDH1A1GLAHTR1AHTR1BMEN1 | |
| SCHEMBL10731475 | 0.84 | ALDH1A1 (0.46) | ALDH1A1GLAHTR1AHTR1BMEN1 | |
| SCHEMBL10731481 | 0.84 | ALDH1A1 (0.46) | ALDH1A1GLAHTR1AHTR1BMEN1 | |
| SCHEMBL10566130 | 0.83 | ALDH1A1 (0.45) | ALDH1A1GLAHTR1AHTR1BMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114044834-A | Polylactic acid fiber and application thereof in adult incontinence nursing pad | 千芝雅(湖北)卫生用品有限公司 | 2022-02-15 | — | — | CN | claimed |
| EP-3710159-A1 | CATALYST COMPONENTS FOR PROPYLENE POLYMERIZATION | W. R. Grace & Co. - Conn. (US) | 2020-09-23 | — | — | EP | claimed |
| US-8344079-B2 | Molar ratio modifications to larger polyolefin catalysts | BASF CORPORATION (US) | 2013-01-01 | — | — | US | claimed |
| JP-2011508053-A | — | — | 2011-03-10 | — | — | JP | claimed |
| EP-2242776-A1 | MOLAR RATIO MODIFICATIONS TO LARGER POLYOLEFIN CATALYSTS | BASF Corporation (US) | 2010-10-27 | — | — | EP | claimed |
| WO-2009088596-A1 | MOLAR RATIO MODIFICATIONS TO LARGER POLYOLEFIN CATALYSTS | BASF CATALYSTS LLC (US) | 2009-07-16 | — | — | WO | claimed |
| US-20090171044-A1 | MOLAR RATIO MODIFICATIONS TO LARGER POLYOLEFIN CATALYSTS | BASF CATALYSTS LLC (US) | 2009-07-02 | — | — | US | claimed |
| EP-0605937-B1 | Antistatic resin composition | DAISO CO LTD (JP) | 1997-06-11 | — | — | EP | claimed |
| EP-0605937-A1 | Antistatic resin composition | DAISO CO., LTD. (JP) | 1994-07-13 | — | — | EP | claimed |
| JP-57130970-A | — | — | None | — | — | JP | disclosed |
| US-20260103548-A1 | PROCESS FOR PRODUCING POLYPROPYLENE-ETHYLENE RANDOM COPOLYMER RESIN WITH SUSTAINABLE REACTOR OPERABILITY | W. R. GRACE & CO.-CONN. | 2026-04-16 | — | — | US | disclosed |
| US-20250243160-A1 | INDOLE DERIVATIVES FOR TARGETING AUTOPHAGY | Automera PTE. LTD (SG) | 2025-07-31 | — | — | US | disclosed |
| US-20250235842-A1 | GAS-PHASE PROCESS FOR MAKING POLYPROPYLENE RANDOM COPOLYMERS | W.R. GRACE & CO.-CONN (US) | 2025-07-24 | — | — | US | disclosed |
| US-20250145745-A1 | HIGH MFR POLYPROPYLENE FOR MELTBLOWN NONWOVEN APPLICATIONS | W. R. GRACE & CO.-CONN. | 2025-05-08 | — | — | US | disclosed |
| US-4221807-A | ADRENERGIC BLOCKING AGENTS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-09-09 | — | — | US | disclosed |
| US-4152446-A | Aminopropanol compounds and compositions for the treatment of cardiac and circulatory diseases | BOEHRINGER MANNHEIM GMBH (DE) | 1979-05-01 | — | — | US | disclosed |
| US-4146630-A | HYPOTENSIVE AGENTS | BOEHRINGER MANNHEIM GMBH (DE) | 1979-03-27 | — | — | US | disclosed |
| US-4144340-A | ADRENERGIC BLOCKING AGENTS | DEUTSCHE GOLD UND SILBER- SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1979-03-13 | — | — | US | disclosed |
| US-4141987-A | HYPOTENSIVE, ADRENERGIC BLOCKING AGENT | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1979-02-27 | — | — | US | disclosed |
| US-4076829-A | Aminopropanol compounds and compositions for the treatment of cardiac and circulatory diseases | BOEHRINGER MANNHEIM GMBH (DT) | 1978-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103548-A1 | PROCESS FOR PRODUCING POLYPROPYLENE-ETHYLENE RANDOM COPOLYMER RESIN WITH SUSTAINABLE REACTOR OPERABILITY | CCT4, PTGER1, TCP1 | ALDH1A1 2941/4885GLA 4060/4885HTR1A 949/4885 |
| US-20250243160-A1 | INDOLE DERIVATIVES FOR TARGETING AUTOPHAGY | SQSTM1, ATG7, BECN1 | ALDH1A1 3383/4885GLA 1842/4885HTR1A 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.